Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Type 1 diabetes for at least 1 year.
- People who use daily long-acting and short-acting insulin injections or doses to manage their diabetes.
- People who are fluent in English.
- Families where a parent or caregiver is able to give consent and the teenager is able to agree to take part in the study.
- Families who have access to video or online health appointments through a phone, tablet, or computer.
Note: The trial is especially focused on recruiting people from groups that are often underrepresented in diabetes research, such as racial and ethnic minorities, families with lower incomes, families using public assistance programs, or people living in rural areas.
Who may not be able to join:
- People who have a cognitive or developmental disorder.
- Young people who are currently a ward of the state (meaning they are under the legal care of a government authority rather than a parent or guardian).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jill Weissberg-Benchell, Ph.D., Ann & Robert H Lurie Children's Hospital of Chicago
Phone: 312-227-3419
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diabetes Distress; Time in Range
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.